Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
32.60
+2.29 (7.56%)
At close: Oct 5, 2026, 4:00 PM EDT
32.87
+0.27 (0.83%)
Pre-market: Oct 6, 2026, 8:28 AM EDT
Schrödinger Revenue
Schrödinger had revenue of $58.89M in the quarter ending June 30, 2026, with 7.54% growth. This brings the company's revenue in the last twelve months to $259.04M, up 8.88% year-over-year. In the year 2025, Schrödinger had annual revenue of $255.87M with 23.29% growth.
Revenue (ttm)
$259.04M
Revenue Growth
+8.88%
P/S Ratio
9.41
Revenue / Employee
$304,747
Employees
850
Market Cap
2.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 255.87M | 48.33M | 23.29% |
| Dec 31, 2024 | 207.54M | -9.13M | -4.21% |
| Dec 31, 2023 | 216.67M | 35.71M | 19.73% |
| Dec 31, 2022 | 180.96M | 43.02M | 31.19% |
| Dec 31, 2021 | 137.93M | 29.84M | 27.60% |
| Dec 31, 2020 | 108.10M | 22.55M | 26.36% |
| Dec 31, 2019 | 85.54M | 18.90M | 28.37% |
| Dec 31, 2018 | 66.64M | 10.95M | 19.65% |
| Dec 31, 2017 | 55.69M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teladoc Health | 2.49B |
| Privia Health Group | 2.36B |
| HealthEquity | 1.36B |
| Omnicell | 1.25B |
| Waystar Holding | 1.21B |
| GoodRx Holdings | 785.23M |
| Doximity | 655.57M |
| Certara | 421.75M |
SDGR News
- 18 days ago - Schrodinger reports inducement grants under Nasdaq listing rule - TheFly
- 19 days ago - Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 21 days ago - Schrödinger Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 27 days ago - Schrodinger announces licensing, collaboration agreement with Tectora - TheFly
- 27 days ago - Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - Business Wire
- 5 weeks ago - Schrödinger to Present at Morgan Stanley Global Healthcare Conference - Business Wire
- 7 weeks ago - Schrodinger assumed with a Neutral at UBS - TheFly
- 7 weeks ago - Schrodinger reports inducement grants under Nasdaq listing rule - TheFly